BILLS-105hr3196ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (4)
the 15th day
3,3′dimethyl[1,1′-biphenyl]-4,4′-diyl)bis[2-[2,4-dichlorophenyl)azo]-3-oxo-
FEBRUARY 11, 1998
December 31, 2002
EVENT (1)
SESSION
H. R. 3196
GPE (4)
Butanamide
3204.17.04
the United States of America
the United States
ORG (9)
N
CONGRESS
THE HOUSE OF REPRESENTATIVES
House of Representa-
SEC
Senate
the
Committee
Ways and Means
PERSON (2)
Butanamide
WEYGAND
Topic Classifications
congressional legislation
98.5%
government oversight
40.8%
public health
34.5%
Extracted Keywords
dimethyl
azo
oxo
bis
suspend december
december duty
suspend
duty
heading
change
sub heading
weygand
tar
section suspension
december
Forensic Analysis
PDF Metadata
- ModDate
- D:20230117183658Z
- Producer
- Acrobat Distiller 2.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:19980213052034Z
Sentiment
Polarity
Positive
0.173
Subjectivity
48%
Objective